Dupixent

TARRYTOWN, N.Y. and PARIS, April 13, 2026 Regeneron Pharmaceuticals, Inc. and Sanofi announced that the European Commission has approved...

PARIS, FRANCE & TARRYTOWN, NEW YORK, USA | March 24, 2026 Sanofi and Regeneron have announced that Japan’s Ministry...

TOKYO, Japan — December 23, 2025 — The Japanese Ministry of Health, Labour and Welfare (MHLW) has granted approval...

SAINT-HERBLAIN, FRANCE — November 26, 2025. Valneva has announced positive final Phase 2 results for its Lyme disease vaccine...

TARRYTOWN, N.Y. & PARIS — November 25, 2025. The European Commission has granted landmark approval for Dupixent® (dupilumab) as...